Joshua Laing, BBiomedSc(Hons), MBBS; Belinda Gabbe, PhD; Zhibin Chen, PhD; et al.
free access
has audio
JAMA Neurol. 2022;79(4):334-341. doi:10.1001/jamaneurol.2021.5420
This cohort study examines data from 15 152 adult patients who had moderate to severe traumatic brain injury to assess risk factors for and outcomes from early posttraumatic seizures.
-
Podcast:
Early Posttraumatic Seizures and Moderate to Severe Traumatic Brain Injury
Lauren Gilstrap, MD, MPH; Weiping Zhou, MS; Marcella Alsan, MD, PhD; et al.
free access
JAMA Neurol. 2022;79(4):342-348. doi:10.1001/jamaneurol.2022.0010
This cross-sectional study uses data from 53.6 million Medicare beneficiaries to assess whether there is an association between regional rates of COVID-19 infection and excess mortality among older adults with or without Alzheimer disease and related dementias residing in the community or nursing homes.
Meng Lee, MD; Chun-Yu Cheng, MD; Yi-Ling Wu, DrPH; et al.
open access
JAMA Neurol. 2022;79(4):349-358. doi:10.1001/jamaneurol.2021.5578
This meta-analysis of randomized clinical trials evaluates the association of more intensive vs less intensive low-density lipoprotein cholesterol–lowering statin-based therapies with outcomes for patients with ischemic stroke.
Cristina Simonet, MD; Jonathan Bestwick, MSc; Mark Jitlal, MSc; et al.
free access
JAMA Neurol. 2022;79(4):359-369. doi:10.1001/jamaneurol.2022.0003
This case-control study examines the presence of prediagnostic signs and symptoms of PD in the primary care setting and individuals of diverse ethnicity and deprived socioeconomic status.
Page B. Pennell, MD; Ashwin Karanam, PhD; Kimford J. Meador, MD; et al.
free access
JAMA Neurol. 2022;79(4):370-379. doi:10.1001/jamaneurol.2021.5487
This cohort study investigates changes in dose-normalized concentrations of the antiseizure medications lamotrigine, levetiracetam, lacosamide, oxcarbazepine, and zonisamide during pregnancy among women with epilepsy.
Sudipto Dolui, PhD; John A. Detre, MD; Sarah A. Gaussoin, MS; et al.
free access
JAMA Neurol. 2022;79(4):380-389. doi:10.1001/jamaneurol.2022.0074
This secondary analysis of a randomized clinical trial evaluates longitudinal arterial spin labeled data to test the hypothesis that long-term intensive treatment does not reduce cerebral blood flow compared with standard treatment.
Ryan L. Hoiland, PhD; Kiran J. K. Rikhraj, MD; Sharanjit Thiara, MD; et al.
free access
JAMA Neurol. 2022;79(4):390-398. doi:10.1001/jamaneurol.2021.5598
This systematic review and meta-analysis evaluates the use of bloodborne brain injury biomarkers for neurologic prognostication in patients with hypoxic ischemic brain injury after cardiac arrest.